10 results
Keyword AmBisome Remove keyword
-
List item
National expert: Helene Van De Ven, Federal Agency for Medicines and Health Products (updated)
- Declaration of interests - 39.39 KB | PDF
- Curriculum Vitae - 26.72 KB | PDF
alternatives to Fungizone® and AmBisome®. J. Control. Release 2012 … -
List item
National expert: Carolina Garcia-Vidal, European Medicines Agency (updated)
- Declaration of interests - 41.86 KB | PDF
- Curriculum Vitae - 58.23 KB | PDF
indication Past 01-01- 2019 31-12- 2022 gilead ambisome IFI Current 01-01- 2022 Pfizer … -
List item
National expert: Paul Knoebl, Austrian Agency for Health and Food Safety (updated)
- Declaration of interests - 46.86 KB | PDF
- Curriculum Vitae - 26.82 KB | PDF
purpura Past 01-09- 2010 01-04- 2014 Gilead Ambisome fungal infections Past 01-04- 2010 01-01- 2012 MSD … -
List item
Human medicine European public assessment report (EPAR): Mycamine
micafungin, Candidiasis
Date of authorisation: 25/04/2008, Revision: 18, Authorised, Last updated: 31/03/2023 -
List item
Human medicine European public assessment report (EPAR): Cancidas (previously Caspofungin MSD)
caspofungin (as acetate), Candidiasis; Aspergillosis
Date of authorisation: 23/10/2001, Revision: 30, Authorised, Last updated: 15/12/2022 -
List item
Human medicine European public assessment report (EPAR): Ecalta
anidulafungin, Candidiasis
Date of authorisation: 20/09/2007, Revision: 24, Authorised, Last updated: 21/03/2023 -
List item
National expert: Peter G Smith, European Medicines Agency (updated)
- Declaration of interests - 43.93 KB | PDF
- Curriculum Vitae - 105.39 KB | PDF
-
List item
Liposomal amphotericin B product-specific bioequivalence guidance (updated)
Last updated: 22/05/2023 -
List item
European Medicines Agency's workshop on nanomedicines
London, from 02/09/2010 to 03/09/2010, Last updated: 08/09/2010 -
List item
Public data from Article 57 database
Last updated: 17/10/2022